Daniel Joseph OConnell - President and CEO, Director at Acumen Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ABOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Daniel Joseph OConnell - trading volume in the past year for Acumen Pharmaceuticals, Inc.

Holdings reported by Daniel Joseph OConnell for Acumen Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 502,485 $1.74 M $3.47 Jan 19, 2024 Direct
Employee Stock Option (right to buy) 602,000 Jan 2, 2024 Direct Common Stock

Transactions reported by Daniel Joseph OConnell for Acumen Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership